Related Experiment Video
Updated: Aug 20, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Albuminuria and tubular markers in juvenile idiopathic arthritis
Ayla Kamburoğlu Göksel1, Lale Sever, Ozgür Kasapçopur
1Department of Pediatric Nephrology and Rheumatology, Cerrahpaşa Medical School, Istanbul University, Turkey.
Insights
Juvenile idiopathic arthritis (JIA) in children does not appear to cause permanent kidney damage, though active disease correlates with increased tubular enzymuria. Treatment with NSAIDs and SAARDs did not show significant differences in renal markers.
Area of Science:
- Pediatric Nephrology
- Rheumatology
- Clinical Chemistry
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic condition in children.
- Potential renal damage from JIA or its treatments (NSAIDs, SAARDs) requires investigation.
Purpose of the Study:
- To assess renal damage in children with JIA.
- To determine if damage is disease-related or treatment-related.
Main Methods:
- Cross-sectional study of 45 JIA patients and 33 controls.
- Measured urinary albumin/creatinine, NAG/creatinine, and beta(2)M/creatinine ratios.
- Analyzed correlations with disease activity and treatment types.
Main Results:
- No significant differences in urinary markers between JIA patients and controls.
- Active JIA correlated with higher NAG/creatinine, linked to inflammation markers (ESR, platelets).
- No association between markers and disease type, activity, or specific medications.
Conclusions:
- Tubular enzymuria (NAG/Cr) increases during active JIA phases.
- Permanent renal damage in JIA appears unlikely.
- Disease activity, not medications, influences transient tubular enzyme elevation.
Abstract:
This study investigates whether renal damage occurs in children with juvenile idiopathic arthritis (JIA) either secondary to the disease per se or due to the side effects of non-steroidal anti-inflammatory drugs (NSAIDs) and slow-acting anti-rheumatic drugs (SAARDs) used in treatment. In this cross-sectional study, albuminuria, N -acetyl glucosaminidase (NAG), beta(2)-microglobulin (beta(2)M), and creatinine (Cr) levels were measured in urine samples of 45 patients (23 female, 22 male, 9.4+/-3.9 years) with JIA and a sex- and age-matched control group of 33 healthy children. The urinary albumin/Cr, NAG/Cr, and beta(2)M/Cr ratios of children with JIA and of the control group did not differ statistically. No difference was noted between patient groups with different types of JIA (12 systemic, 18 polyarticular, and 15 oligoarticular JIA). JIA patients with active disease (n=16) had higher NAG/Cr values than patients with inactive disease (P=0.002). NAG/Cr levels correlated with erythrocyte sedimentation rate (r=0.66, P<0.001) and platelet count (r=0.61, P<0.001) and showed a slight correlation with the number of joints with active arthritis in children with polyarticular JIA (r=0.45, P=0.055). Neither beta(2)M/Cr nor albumin/Cr ratios were associated with disease activity. No difference was noted between patient groups treated with different NSAIDs and SAARDs. In children with JIA tubular enzymuria increases during the active phase of the disease; however, it seems that permanent renal damage does not occur.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Urine Studies I: Urinalysis
Acute Kidney Injury III: Clinical Manifestations
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
